interim data from can-003 clinical trial, page-15

Sorry to butt in guys, don't have the intellect to match it with you.
But, aren't these results pretty much what we expected? It was never meant to show that Cvac is a cure, just slow down progression, which it is. For interim results, I thought they were pretty good. Final results should give a much clearer picture on PFS but OS stats should be the most interesting down the track.
Also, the point about CANVAS recruiting 1st remission only, leaving no funding for a 2nd remission data? Surely candidates will not be thrown out of the trial when they do progress? So that data will accumulate under the current trial?